Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Endo Health Solutions Inc    ENDP

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 

Senate Panel Seeks Info From J&J, Endo, Others Over Concern On Painkiller Marketing -Reuters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/09/2012 | 08:44pm CEST

The Senate Finance Committee is looking into possible links between three drug companies and nonprofit medical groups, citing concerns about the groups' advocacy of painkillers, Reuters reported Wednesday.

The panel sent letters to Johnson & Johnson (JNJ), Endo Pharmaceuticals Holdings Inc. (>> Endo Pharmaceuticals Holdings Inc) and Purdue Pharma LP and seven medical groups seeking documents about their financial connections, Reuters reported.

Sen. Max Baucus (D., Mont.), the committee's chairman, said in a statement that "painkillers have an important role in health care when prescribed and used properly, but pushing misinformation on consumers to boost profits is not only wrong, it's dangerous," Reuters reported.

Reuters said officials at the three drug companies weren't immediately available for comment.

Full story at http://www.reuters.com/article/2012/05/09/us-usa-painkillers-investigation-idUSBRE84811420120509

-Dow Jones Newswires; 212-416-2900

Stocks mentioned in the article : Endo Pharmaceuticals Holdings Inc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ENDO HEALTH SOLUTIONS INC
02/08 Canada's TMX seeks part of Saudi Aramco listing
01/24 U.S. reaches settlement with Endo on pay-for-delay charges
01/12 ENDO INTERNATIONAL PLC : Biotech and Healthcare Stocks Hit Hard by President Tru..
01/04 ENDO INTERNATIONAL PLC : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of..
2016 U.S. stock market performance in 2016
2016 ENDO INTERNATIONAL PLC : Bronstein, Gewirtz & Grossman, LLC Reminds Investors of..
2016 ENDO INTERNATIONAL PLC : Lundin Law PC Announces Securities Class Action Lawsuit..
2016 ENDO INTERNATIONAL PLC : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC ..
2016 ENDO INTERNATIONAL PLC : Levi & Korsinsky, LLP Notifies Shareholders of Endo Int..
2016 ENDO INTERNATIONAL PLC : SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC ..
More news
Sector news : Generic Pharmaceuticals
10:10aDJASTRAZENECA : Profit Drops on Decline in Blockbuster-Drug Revenue -- Update
09:41aDJASTRAZENECA : Correction to AstraZeneca Profit Drops on Decline in Blockbuster-D..
09:26aDJBAYER : First-Quarter Net Profit Up 38% at EUR2.08 Billion -- Update
08:48aDJGLAXOSMITHKLINE : New Glaxo CEO Seeks Tighter Drug Focus -- WSJ
08:45aDJASTRAZENECA : Profit Drops on Decline in Blockbuster-Drug Revenue
More sector news : Generic Pharmaceuticals
Advertisement
Financials ($)
Sales 2017 3 540 M
EBIT 2017 1 407 M
Net income 2017 271 M
Debt 2017 5 068 M
Yield 2017 -
P/E ratio 2017 1 115,00
P/E ratio 2018 9,18
EV / Sales 2017 2,13x
EV / Sales 2018 2,81x
Capitalization 2 486 M
More Financials
Technical analysis trends ENDO HEALTH SOLUT...
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 15,7 $
Spread / Average Target 41%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Paul V. Campanelli President, Chief Executive Officer & Director
Roger H. Kimmel Chairman
Terrance J. Coughlin Chief Operating Officer & Executive Vice President
Blaise Coleman Chief Financial Officer & Executive Vice President
Robert J. Cobuzzi SVP-Operations, Research & Development Strategy
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ENDO HEALTH SOLUTIONS ..2 486
OTSUKA HOLDINGS CO LTD1.71%25 972
SUN PHARMACEUTICAL IND..2.63%24 056
ONO PHARMACEUTICAL CO...-11.80%11 951
SHANGHAI FOSUN PHARMAC..29.17%10 264
ASPEN PHARMACARE HOLDI..-2.28%9 595
More Results